Perforation of the ileum due to Crohn's disease in a teenager without previous diarrhea case report
Article Sidebar
Main Article Content
Abstract
Crohn disease is of immunological origin, in which an inflammatory condition occurs that can be located anywhere in the intestine, especially in the ileocecal part. It is usually characterized by diarrhea and pain with weight loss. The present case is of a 15-year-old girl who abruptly debuts with abdominal right iliac fossa (RIF) pain, which suggests an appendicular condition, so she underwent surgery. In later days, he presented persistent vomiting, suspected of an obstructive condition. A second surgical intervention shows an inflammatory condition at the ileocecal level, so a colostomy and ileostomy are performed. Biopsy showed lesions consistent with Crohn's disease. Treatment with mesalazine and azathioprine was performed, achieving a remission of the picture. Six months later an anastomosis was performed with a favorable evolution of the patient.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Ballester Ferré MP, Boscá-Watts MM, Mínguez Pérez M. Crohn's disease. Med Clin (Barc). 13 de julio de 2018;151(1):26-33. DOI: https://doi.org/10.1016/j.medcli.2017.10.036
Aminosalicilatos para la inducción de remisión o respuesta en la enfermedad de Crohn - Lim, WC - 2016 | Cochrane Library [Internet]. [citado 3 de noviembre de 2021]. Disponible en: https://www.cochranelibrary.com/es/cdsr/doi/10.1002/14651858.CD008870.pub2/full /es
Gjuladin-Hellon T, Iheozor-Ejiofor Z, Gordon M, Akobeng AK. Azathioprine and 6- mercaptopurine for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database of Systematic Reviews [Internet]. 2019 [citado 3 de noviembre de 2021];(8). Disponible en: https://www.cochranelibrary.com/es/cdsr/doi/10.1002/14651858.CD010233.pub3/full/es DOI: https://doi.org/10.1002/14651858.CD010233.pub3
Rodríguez MG, editor. ENFERMEDAD DE CROHN [Internet]. Vols. LXIX, 153–156. REVISTA MEDICA DE COSTA RICA Y CENTROAMÉRICA; 2012 [citado el 28 de junio de 2021]. Disponible en: https://studylib.es/doc/6928967/enfermedad-de-crohn
Silva F, Gatica T, Pavez C. ETIOLOGÍA Y FISIOPATOLOGÍA DE LA ENFERMEDAD INFLAMATORIA INTESTINAL. Rev médica Clínica Las Condes. 2019;30(4):262–72. DOI: https://doi.org/10.1016/j.rmclc.2019.06.004
Torreblanca Xiques A. Enfermedad de Crohn. Rev. electron. Zoilo [Internet]. 2015 [citado 25 Jun 2021]; 40(3): [aprox. 0 p.]. Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/92
Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut. 1997 Apr;40(4):443-8. doi: 10.1136/gut.40.4.443. PMID: 9176068; DOI: https://doi.org/10.1136/gut.40.4.443
PMCID: PMC1027115.
Mark A Peppercorn, MD Sunanda V Kane, M D, MSPH. Clinical manifestations, diagnosis, and prognosis of Crohn disease in adults [Internet]. Uptodate.com. 2020 [citado el 28 de junio de 2021]. Disponible en: https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-prognosisof-crohn-disease-in-adults?search=Clinical%20manifestations,%20diagnosis,%20and%20prognosis%20of%20Crohn%20disease%20in%20adults&source=search_result&seletedTitle=1~150&usage_type=default&display_rank=1
Dip DP. “Varón de 39 años con enfermedad de Crohn, síndrome febril y desnutrición.”[Internet]. Com.ar. 16 de octubre de 2014 [citado el 1 de julio de 2021]. Disponible en: http://www.clinica-unr.com.ar/2015-web/SemCentral/373/SemCentral_373_Pag2.htm
Rodríguez-Moranta F, Lobatón T, Rodríguez-Alonso L, Guardiola J. Calprotectina fecal en e l diagnóstico de enfermedad es inflamatorias. Gastroenterol Hepatol [Internet]. 2013 [citado el 28 de junio de 2 0 2 1 ] ; 3 6 ( 6 ): 400 – 6 . Disponible en: https://www.elsevier.es/es-revista-gastroenterologia-hepatologia-14-articulocalprotectina-fecal-el-diagnostico-enfermedades-S0210570513000046
Chande N, Townsend CM, Parker CE, Mac Donald J K. Azathioprineor6-mercaptopurine for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2016;10(10):CD000545. DOI: https://doi.org/10.1002/14651858.CD000545.pub5
Otoya Moreno G, Borda L, Chiroque L, Grazia Venturelli M. Crohn's disease: clinical case and review of the literature. Rev Gastroenterol Perú. 2014; [Internet]. 2014 Oct [citado 2021 Jun 27] 34(4):339–44.
Terdiman JP, Gruss CB, Heidelbaugh JJ, Sultan S, Falck-Ytter YT; AGA Institute Clinical Pr a c t i c e a n d Q u a l i t y M a n a g e m e n t Committee. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology. 2013 Dec; 145 (6): 14 59 - 6 3. doi: 10.1053/j.gastro.2013.10.047. PMID:24267474. DOI: https://doi.org/10.1053/j.gastro.2013.10.047
Furusho JKY. Terapia biológica en la enfermedad inflamatoria intestinal. Revista de gastroenterología de México. 2010
noviembre; 75(S2).
Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340(18):1398–405. DOI: https://doi.org/10.1056/NEJM199905063401804
Moreau AC, Paul S, Del Tedesco E, et al. Asociación entre los niveles de nucleótidos de 6-tioguanina y la remisión clínica en la enfermedad inflamatoria: un metaanálisis. Inflamm Bowel Dis 2014; 20: 464. DOI: https://doi.org/10.1097/01.MIB.0000439068.71126.00
Bermejo F, Aguas M, Chaparro M, Domènech E, Echarri A, García-Planella E, et al. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el uso de tiopurinas en la enfermedad inflamatoria intestinal. Gastroentero l Hepatol. 2018;41(3):205–21. DOI: https://doi.org/10.1016/j.gastrohep.2017.11.007
B. HM, L. y. PI. Clasificación de la gravedad de la enfermedad inflamatoria intestinal [Internet]. Gastrolat.org. [citado el 29 de junio de 2021]0. Disponible en: https://gastrolat.org/DOI/PDF/10.0716/gastrolat2013n200006.pdf
Mengual-Ballester M, García-Marín JA, Pellicer-Franco E, Guillén-Paredes MP, García-García ML, Cases-Baldó MJ, et al. Protective ileostomy: complications and mortality associated with its closure. Rev Esp Enferm
Dig. 2012;104(7):350–4. DOI: https://doi.org/10.4321/S1130-01082012000700003
Phillip R Fleshner, MD, FACS. Operative management of Crohn disease of the small bowel, colon, and rectum [Internet]. Uptodate.com. [citado el 28 de junio de 2 0 2 1 ] . D i s p o n i b l e e n : https://www.uptodate.com/contents/operative-management-of-crohn-disease-of-thes-m allbowelcolonandrectumsearch=Operative%20management%20of%20Crohn%20disease%20of%20the%20small%20bowel,%20colon,%20and%20rectum&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
Walfish AE, Companioni RAC. Enfermedad de Crohn [Internet]. Msdmanuals.com. 2020 [citado el 1 de julio de 2021]. Disponible en: https://www.msdmanuals.com/es-pe/professional/trastornos-gastrointestinales/enfermedad-inflamatoria-intestinal-ibd/enfermedad-decrohn